InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Browse the detailed record of transactions filed by Larson Tina Marriott, Chief Operating Officer. Insider active across 1 companies, notably Recursion Pharmaceuticals, INC.. Aggregated, 11 reports have been recorded. Total volume traded: €97k. The latest transaction was filed on 16 May 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations11 total
€7,9191,458 shares@ €5.43160.0004% mcap4.3% of flow
Class A Common Stock
SEC:0001209191-22-030247:0·
€56,03258,500 shares@ €0.95780.0026% mcap30.6% of flow
Class A Common Stock
SEC:0001209191-22-017387:0·
€14,92116,000 shares@ €0.93260.0007% mcap8.1% of flow
Class A Common Stock
SEC:0001209191-22-011969:0·
€3,7314,000 shares@ €0.93270.0002% mcap2.0% of flow
Class A Common Stock
SEC:0001209191-22-010496:0·
€3,7314,000 shares@ €0.93277.1% of flow
Class A Common Stock
SEC:0001209191-22-010496·
079,613 shares0
Class A Common Stock
SEC:0001209191-22-007911:0·
079,613 shares0
Class A Common Stock
SEC:0001209191-22-007911·
€18,5841,160 shares@ €16.020535.6% of flow
Class A Common Stock
SEC:0001209191-21-070631·
€18,5841,160 shares@ €16.02050.0009% mcap10.1% of flow
Class A Common Stock
SEC:0001209191-21-070631:0·
€29,8811,798 shares@ €16.618857.2% of flow
Class A Common Stock
SEC:0001209191-21-066261·
€29,8811,798 shares@ €16.61880.0014% mcap16.3% of flow
Class A Common Stock
SEC:0001209191-21-066261:0·
11 of 11 declarations
About Larson Tina Marriott
Tina Marriott Larson is the President and COO of Recursion Pharmaceuticals, Inc. In this role, she oversees the company's operations and contributes to the implementation of its strategy. Her expertise in the biopharmaceutical sector enables her to effectively lead Recursion's initiatives.
